[1]CurrentPatentAssignee:BAYERAG-WO2012/143329,2012,A1Locationinpatent:Page/Pagecolumn177-178
176961-57-2
1072944-42-3
889676-36-2
1072944-35-4
1072944-38-7
1072944-37-6
171557-83-8 | 6,6-Dimethyl-5-oxoheptanoic acid | AA007TPE | MFCD01320156
1744-22-5 | 2-Amino-6-(trifluoromethoxy)benzo[d]thiazole | AA007UEE | MFCD00210213
110464-72-7 | 4-Methoxy-3,5-dimethylpyridine-2-carbaldehyde | AA007V16 | MFCD12031924
17259-32-4 | 4-(6-Chloropyridazin-3-yl)morpholine | AA007VQA | MFCD00574575
1098-60-8 | Triflupromazine hydrochloride | AA007WAN | MFCD00058103
15177-57-8 | 3,5-Dichloropyridine 1-oxide | AA007WR9 | MFCD00955620
154743-05-2 | Sulfamide, N-ethyl-N-methyl- | AA007XCS | MFCD11623179
153863-35-5 | (5-Methyl-1-phenyl-1h-pyrazol-4-yl)methanol | AA007XSU | MFCD02682046
152594-70-2 | 4-(4-Hydroxyphenyl)phthalazin-1(2H)-one | AA007YHV | MFCD02606561
139332-94-8 | L-Cysteine,N-acetyl-S-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraen-1-yl]- | AA007Z9G | MFCD00216147